Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NeuPath HealthTSXV:NPTH 39 PB Ratio is 1.36 as of Aug. 28, 2026, which is 100% above its 10-year median of 0.68. GuruFocus rates TSXV:NPTH with a GF Score™ of 39/100 and a GF Value™ of C$0.25 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 614 Healthcare Providers & Services companies, NeuPath Health ranks better than 67.43% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-08-28), NeuPath Health's share price is C$0.55. NeuPath Health's Book Value per Share for the quarter that ended in Jun. 2026 was C$0.40. Hence, NeuPath Health's PB Ratio of today is 1.36.
The historical rank and industry rank for NeuPath Health's PB Ratio or its related term are showing as below:
TSXV:NPTH'
s PB Ratio Range Over the Past 10 Years
Min: 0.23 Med: 0.68 Max: 1.79
Current: 1.37
During the past 7 years, NeuPath Health's highest PB Ratio was 1.79. The lowest was 0.23. And the median was 0.68.
TSXV:NPTH's PB Ratio is ranked better than 67.43% of 614
companies
in the Healthcare Providers & Services industry
Industry Median: 1.995
vs TSXV:NPTH: 1.37
During the past 12 months, NeuPath Health's average Book Value Per Share Growth Rate was 6.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -5.40% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -11.30% per year.
During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of NeuPath Health was 8.10% per year. The lowest was -15.90% per year. And the median was -8.65% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
NeuPath Health PB Ratio Related Terms
NeuPath Health PB Ratio Historical Data
* Premium members only.
The historical data trend for NeuPath Health's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, NeuPath Health's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NeuPath Health PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, NeuPath Health's PB Ratio distribution charts can be found below:
* The bar in red indicates where NeuPath Health's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
NeuPath Health's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
NeuPath Health (TSXV:NPTH) has a PB Ratio of 1.36 as of Aug. 28, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on NeuPath Health and its competitors. This is 100% above median its historical median of 0.68. Over the past decade, NeuPath Health's PB Ratio has ranged from 0.23 to 1.79. According to the industry distribution chart, NeuPath Health ranks #200 out of 614 companies in the Healthcare Providers & Services industry, placing it in the top 32.6%.
Is NeuPath Health's PB Ratio too high?
NeuPath Health's current PB Ratio of 1.36 is 100% above median its 10-year median of 0.68. Over the past 10 years, this metric has ranged from a low of 0.23 to a high of 1.79. The Healthcare Providers & Services industry median PB Ratio is 2.00. NeuPath Health's value of 1.36 is 31.8% below this industry median. Based on the distribution chart, NeuPath Health ranks #200 out of 614 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, NeuPath Health has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NeuPath Health's PB Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, NeuPath Health ranks #200 out of 614 companies for PB Ratio. This puts NeuPath Health in the upper half of its industry. The industry median PB Ratio is 2.00. NeuPath Health's value of 1.36 is 31.8% below this benchmark. Historically, NeuPath Health's own PB Ratio has ranged from 0.23 to 1.79 over the past decade. While the company's 10-year median is 0.68 vs. the industry median of 2.00, NeuPath Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 2.00, based on 614 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NeuPath Health's current PB Ratio of 1.36 is 31.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on NeuPath Health and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NeuPath Health's current PB Ratio is 1.36, which is 100% above median its own 10-year median of 0.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NeuPath Health stock overvalued right now?
Based on GuruFocus' analysis, NeuPath Health (TSXV:NPTH) is currently considered Significantly Overvalued. The stock's GF Value™ is C$0.25, compared to a current price of C$0.55 — trading 120% above its estimated fair value. The current PB Ratio is 1.36, which is 100% above median its 10-year median of 0.68 and 31.8% below the Healthcare Providers & Services industry median of 2.00. NeuPath Health's overall GF Score™ is 39/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For NeuPath Health (TSXV:NPTH), the current PB Ratio is 1.36 as of Aug. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NeuPath Health (TSXV:NPTH) Overvalued in 2026?
Based on GuruFocus' analysis, NeuPath Health stock appears to be overvalued.
The current stock price of C$0.55 is trading 120% above its estimated GF Value™ of C$0.25.
GuruFocus considers NeuPath Health to be Significantly Overvalued.
Key valuation signals for TSXV:NPTH:
PB Ratio: 1.36 (100% above median its 10-year median of 0.68)
GF Value™: C$0.25 vs. price of C$0.55 (120% above fair value)
Industry Position: 31.8% below the Healthcare Providers & Services median (#200 of 614)
No single metric tells the full story. See the TSXV:NPTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NeuPath Health Inc operates an end-to-end, integrated network of healthcare businesses. It utilizes research, data-driven insights, technology, and interdisciplinary care to help restore function for patients impacted by acute and chronic musculoskeletal conditions, including chronic pain, spinal injuries, sports-related injuries, and concussions. It operates an interdisciplinary network of medical clinics in Ontario and Alberta, in addition to an independent medical assessment business with a national network of healthcare providers. Its medical clinics provide comprehensive assessments and rehabilitation services to clients with chronic pain, musculoskeletal or back injuries, sports-related injuries, and concussions. The company operates in one industry segment: medical services.
39GF Score
Get the complete analysis for TSXV:NPTH
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:NPTH has been successfully added to your 
